DOYLE III, Santa Barbara, CA We present clinical results of an automated subcutaneous insulin delivery system for subjects with diabetes that demonstrates safety, therapeutic efficacy, and minimal user intervention. The insulin delivery system is comprised of a CSII pump (OmniPod, Insulet Corp) and ...